MEMBERS AREA
Bonjour
Upcoming meetings
____________________________
05 avril 2018 – réunion WP2
06 avril 2018 – rapport annuel scientifique et financier -ANR
19 avril 2018 – réunion WP5
Etat d’avancement
WP2 – New functions of PCSK9
- Task 1 – PCSK9 and intestine 75%
- Task 2 – PCSK9 and Lp(a) 100%
- Task 3 – PCSK9 and diabetes 100%
- Task 4 – PCSK9 and iPSC 51%
WP4 – Assessing the long-term safety of low LDL-C levels
- Task 1 – Phenotyping of FHBL patients 16%
- Task 2 – Assessing the prevalence of FHBL in a sychiatric population – PARTITION 37%
WP3 – Novel CV markers and protecting factors in FH
- Task 1 – SAFIR study 50%
- Task 2 – Genetics of CV protection in FH 20%
- Task 3 – Biomarkers of CV protection in FH 23%
- Task 4 – Validate new drug targets in CV protection 0%
WP5 – A genetically-based strategy to identify new targets in LDL-C metabolism
- Task 1 – HYPOCHOL study 30%
- Task 2 – Identifying new genes in FHBL and FH 25%
- Task 3 – Functional characterization of new genes in FHBL and FH 40%
Work group documents